All In MedTech

Device Trial Radar · NCT06692153

Embecta AID System in Adults With Type 2 Diabetes

A Multicenter, Pivotal, Randomized Controlled Trial Comparing the Safety and Efficacy of an Automated Insulin Delivery System With the Standard of Care in Adults With Type 2 Diabetes (EMBRACE-T2D)

Last checked: Nov 19, 2026Latest source record: Dec 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

WithdrawnPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Withdrawn

Enrollment

0

Actual

Start

Jan 2025

Primary completion

Mar 2026

Study completion May 2026

Sponsor

Lead sponsor
Embecta Corp.Not on our public-company list
Sponsor type
Industry
Collaborators
Jaeb Center for Health Research
First posted
Nov 18, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized control study that will evaluate the safety and effectiveness of the embecta Automated Insulin Delivery System in adults with Type 2 diabetes requiring insulin therapy

Conditions

  • Type 2 Diabetes
  • Type 2 Diabetes Mellitus (T2DM)
  • Type 2 DM
  • T2DM With Inadequate Glycemic Control
  • T2DM (Type 2 Diabetes Mellitus)
  • T2D
  • T2DM

Interventions

  • An AID System.Device

    The embecta Automated Insulin Delivery (AID) System is a closed loop system comprised of 3 components: the embecta insulin pump, a Smartphone with the Tidepool Loop app, and the Dexcom G6 CGM

  • Standard of Care (SC)Other

    Participants will continue to use their current therapy for T2D.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. HbA1c changeTime frame: 13 weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford

    Palo Alto, California

  • Diablo Research

    Walnut Creek, California

  • Indiana Universtiy School of Medicine

    Indianapolis, Indiana

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.